tiprankstipranks
Jazz upgraded to Overweight at Morgan Stanley after Ziihera launch
PremiumThe FlyJazz upgraded to Overweight at Morgan Stanley after Ziihera launch
2M ago
ALX Oncology announces results from Phase 1b/2 trial
Premium
The Fly
ALX Oncology announces results from Phase 1b/2 trial
2M ago
Jazz Pharmaceuticals’ Ziihera now included in updated NCCN guidelines
Premium
The Fly
Jazz Pharmaceuticals’ Ziihera now included in updated NCCN guidelines
2M ago
Jazz Pharmaceuticals announces FDA approval of Ziihera in BTC
PremiumThe FlyJazz Pharmaceuticals announces FDA approval of Ziihera in BTC
2M ago
Jazz Pharmaceuticals price target raised to $162 from $154 at Baird
Premium
The Fly
Jazz Pharmaceuticals price target raised to $162 from $154 at Baird
2M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
Zymeworks upgraded to Outperform from Market Perform at Leerink
PremiumThe FlyZymeworks upgraded to Outperform from Market Perform at Leerink
3M ago
Jazz Pharmaceuticals Reports Strong Q3 2024 Growth
Premium
Company Announcements
Jazz Pharmaceuticals Reports Strong Q3 2024 Growth
3M ago
Jazz Pharmaceuticals reports Q3 adjusted EPS $6.61, consensus $5.50
Premium
The Fly
Jazz Pharmaceuticals reports Q3 adjusted EPS $6.61, consensus $5.50
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100